Vol3 Issue1

Vol3 Issue1 _1

posted Oct 23, 2018, 1:42 AM by Yaseen Raouf Mohammed   [ updated Nov 19, 2018, 12:11 AM ]


 Dana Khdr Sabir

 Department of Medical Laboratory Science, Charmo University, 46023 Chamchamal, Sulaimani, Kurdistan Region, Iraq

Acinetobacter baummannii is aerobic, Gram negative and multidrug resistant bacterium (MDR) which is the main cause of the hospital acquired infection.Using nanoparticle as antimicrobial agents is a promising method to overcome the threat of MDR bacteria, this is not only because the natural effective properties of these particles against the bacterial cells, but it is also unlikely that microorganisms gain resistant against nanoparticles. In this study, silver nanoparticles (Ag-NPs) and synergistic effect of Ag-NPs with different antibiotics were tested against A. baummannii strain H72721 in Tryptic Soy Broth (TSB). Minimum inhibitory concentration (MIC) of each of the ampicillin, kanamycin, gentamycin and clindamycin on the bacterium was 11 mg/ml, 2 mg/ml, 0.5 mg/ ml, and 0.3 mg/ml respectively. In addition, MIC of the Ag-NPs alone towards the bacterial strain was found as (0.75 mg ml- 1). Interestingly, the inhibitory property of each of the tested antibiotics were greatly improved when they were used in combination with Ag-NPs compare to when they were used alone, and in case of each of the ampicillin and clindamycin the bacterial growth reduced 3 folds. Results from this study are strongly suggesting that Ag-NPs could be provide a successful approach to overcome the problem of MDR bacteria and could use as a superficial treatment for A. baummannii’s infections.

multidrug resistance, minimuminhibitory concentration, silver nanoparticles

Antibiotic resistance threats in the United States.
2013, Centers for Disease Control and Prevention.
Acinetobacter baumannii infections among patients at
military medical facilities treating injured U.S. service
members, 2002-2004. MMWR Morb Mortal Wkly
Rep, 2004. 53(45): p. 1063-6.
Davis, K.A., et al., Multidrug-Resistant Acinetobacter
Extremity Infections in Soldiers. Emerging Infectious
Diseases, 2005. 11(8): p. 1218-1224.
Howard, A., et al., Acinetobacter baumannii: an
emerging opportunistic pathogen. Virulence, 2012.
3(3): p. 243-50.
Turton, J.F., et al., Comparison of Acinetobacter
baumannii Isolates from the United Kingdom and the
United States That Were Associated with Repatriated
Casualties of the Iraq Conflict. Journal of Clinical
Microbiology, 2006. 44(7): p. 2630-2634.
Rice, L.B., Challenges in identifying new antimicrobial
agents effective for treating infections with Acinetobacter
baumannii and Pseudomonas aeruginosa. Clin
Infect Dis, 2006. 43 Suppl 2: p. S100-5.
Alsan, M. and M. Klompas, Acinetobacter baumannii:
An Emerging and Important Pathogen. Journal of
clinical outcomes management : JCOM, 2010. 17(8):
p. 363-369.
Urban, C., S. Segal-Maurer, and J.J. Rahal, Considerations
in Control and Treatment of Nosocomial
Infections Due to Multidrug-Resistant Acinetobacter
baumannii. Clinical Infectious Diseases, 2003. 36(10):
p. 1268-1274.
Harding, C.M., S.W. Hennon, and M.F. Feldman, Uncovering
the mechanisms of Acinetobacter baumannii
virulence. Nature Reviews Microbiology, 2018. 16(2):
p. 91.
WHO, Global priority list of antibiotic-resistant bacteria
to guide research, discovery, and development of
new antibiotics. Geneva: World Health Organization,
Pal, S., Y.K. Tak, and J.M. Song, Does the Antibacterial
Activity of Silver Nanoparticles Depend on the
Shape of the Nanoparticle? A Study of the Gram-Negative
Bacterium Escherichia coli. Applied and Environmental
Microbiology, 2007. 73(6): p. 1712-1720.
Stoimenov, P.K., et al., Metal Oxide Nanoparticles
as Bactericidal Agents. Langmuir, 2002. 18(17): p.
Li, P., et al., Synergistic antibacterial effects of β-lactam
antibiotic combined with silver nanoparticles.
Nanotechnology, 2005. 16(9): p. 1912-1917.
Chudobova, D., et al., Effect of Ampicillin, Streptomycin,
Penicillin and Tetracycline on Metal Resistant and
Non-Resistant Staphylococcus aureus. International
Journal of Environmental Research and Public Health,
2014. 11(3): p. 3233-3255.
Kohanski, M.A., D.J. Dwyer, and J.J. Collins, How
antibiotics kill bacteria: from targets to networks.
Nature reviews. Microbiology, 2010. 8(6): p. 423-435.
Abdel Rahim, K.A. and A.M. Ali Mohamed, Bactericidal
and Antibiotic Synergistic Effect of Nanosilver
Against Methicillin-Resistant Staphylococcus aureus.
Jundishapur J Microbiol, 2015. 8(11): p. e25867.
Kim, S.-H., et al., Antibacterial activity of silver-
nanoparticles against Staphylococcus aureus and
Escherichia coli. Korean J. Microbiol. Biotechnol,
2011. 39(1): p. 77-85.
Gao, M., et al., Controlled synthesis of Ag nanoparticles
with different morphologies and their antibacterial
properties. Materials Science and Engineering: C,
2013. 33(1): p. 397-404.
McShan, D., et al., Synergistic antibacterial effect
of silver nanoparticles combined with ineffective
antibiotics on drug resistant Salmonella typhimurium
DT104. Journal of Environmental Science and Health,
Part C, 2015. 33(3): p. 369-384.

View All Artical

1-1 of 1